A Retrospective Evaluation of PD-L1 Expression and Heterogeneity in Early-Stage Non-Small Cell Lung Cancer (REPLICA)
Clinical Lung Cancer · 2025
DOI: 10.1016/j.cllc.2025.01.008 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Lung Cancer, 2025. Verfasst von Eleni C Josephides und 18 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Centre at Guy's, Guy's and St Thomas' NHS Foundation Trust, London, UK; School of Cancer and Pharmaceutical Sciences, King's College London, L…. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, B7-H1 Antigen, Lung Neoplasms, Biomarkers, Tumor. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: Merck Sharp & Dohme UK Ltd.
Abstract (Originalsprache)
BACKGROUND: Immune checkpoint inhibitors have improved survival in patients with non-small cell lung cancer (NSCLC). Whilst PD-L1 expression is a useful predictive biomarker, data on concordance of expression between primary tumor and nodal metastases in the surgical setting are sparse. METHODS: We assessed PD-L1 expression in paired primary tumor and involved lymph node samples from 451 consecutive patients with stage IIB-IIIB NSCLC who underwent curative lung resection and lymphadenectomy at our institution between 2009 and 2018, to assess intertumor heterogeneity. Clinical records were examined to determine survival outcomes, and relationship to PD-L1 expression was explored. RESULTS: Using PD-L1 expression categories of 50%) level. It was more common for PD-L1 expression to be higher in the primary tumor than its metastatic lymph node than the converse. PD-L1 expression irrespective of site, had no significant impact on disease-free or overall survival. CONCLUSION: Our study confirms the heterogeneity of PD-L1 expression in early-stage NSCLC and suggests that a biopsy specimen from a single site may not be a comprehensive representation of PD-L1 expression. The proportion of tumours with high PD-L1 expression appears lower in early-stage NSCLC than in advanced disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cancer Centre at Guy's, Guy's and St Thomas' NHS Foundation Trust, London, UK; School of Cancer and Pharmaceutical Sciences, King's College London, London, UK.
- Cancer Centre at Guy's, Guy's and St Thomas' NHS Foundation Trust, London, UK.
- Cancer Centre at Guy's, Guy's and St Thomas' NHS Foundation Trust, London, UK; School of Cancer and Pharmaceutical Sciences, King's College London, London, UK; King's College Hospital NHS Foundation Trust, King's Colleg…
- Cancer Centre at Guy's, Guy's and St Thomas' NHS Foundation Trust, London, UK; School of Cancer and Pharmaceutical Sciences, King's College London, London, UK; Medical Research Council Clinical Trials Unit at UCL, Insti…
- Royal College of Radiologists Fellow, Guy's and St Thomas' NHS Foundation Trust, London, UK; Comprehensive Cancer Centre, King's College, London, UK.
- Department of Cancer Imaging, School of Biomedical Engineering and Imaging Sciences, King's College London, London, UK; PET Centre, King's College London & Guy's and St. Thomas', London, UK.
Förderung
- Merck Sharp & Dohme UK Ltd
Zitieren
APA
Josephides, E. C., Smith, D., Bille, A., Patel, A., Rush, H. L., Dunn, R., Hughes, D. J., Hunter, S., Taniere, P., Crawley, D., Monroy-Iglesias, M., Henry, A. R., Montes, A., Van Hemelrijck, M., Spicer, J., Josephs, D., Santis, G., Nonaka, D., & Karapanagiotou, E. M. (2025). A Retrospective Evaluation of PD-L1 Expression and Heterogeneity in Early-Stage Non-Small Cell Lung Cancer (REPLICA). Clinical Lung Cancer. https://doi.org/10.1016/j.cllc.2025.01.008
Vancouver
Josephides EC, Smith D, Bille A, Patel A, Rush HL, Dunn R, et al. A Retrospective Evaluation of PD-L1 Expression and Heterogeneity in Early-Stage Non-Small Cell Lung Cancer (REPLICA). Clinical Lung Cancer. 2025. doi:10.1016/j.cllc.2025.01.008
BibTeX
@article{Josephides2025,
author = {Josephides, Eleni C and Smith, Daniel and Bille, Andrea and Patel, Akshay and Rush, Hannah L and Dunn, Roberta and Hughes, Daniel J and Hunter, Sarah and Taniere, Phillipe and Crawley, Danielle and Monroy-Iglesias, Maria and Henry, Annie-Rose and Montes, Ana and Van Hemelrijck, Mieke and Spicer, James and Josephs, Debra and Santis, George and Nonaka, Daisuke and Karapanagiotou, Eleni M},
title = {A Retrospective Evaluation of PD-L1 Expression and Heterogeneity in Early-Stage Non-Small Cell Lung Cancer (REPLICA)},
journal = {Clinical Lung Cancer},
year = {2025},
doi = {10.1016/j.cllc.2025.01.008}
}
EUVIMED